推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial

[HTML] from ascopubs.orgAK Burnett, RK Hills, D Milligan… - Journal of Clinical …, 2011 - jco.ascopubs.org
... Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of
Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial. ... Vellenga E,; Griffin JD. (1987) The
biology of acute myeloblastic leukemia. Semin Oncol 14:365–371. ...
Cited by 18 - Related articles - All 5 versions

Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker

M Jan, MP Chao, AC Cha… - Proceedings of the …, 2011 - National Acad Sciences
... Prospective separation of normal and leukemic stem cells based on differential expression of
TIM3, a human acute myeloid leukemia stem cell marker. ... PCT/US2009/000224 entitled “Markers
of Acute Myeloid Leukemia Stem Cells.”. This article is a PNAS Direct Submission. ...
Related articles - All 3 versions

Acute myeloid leukemia: leukemia stem cells write a prognostic signature

[PDF] from stemcellres.comEJ Gudgin… - Stem Cell Research & Therapy, 2011 - Springer
Page 1. Acute myeloid leukemia (AML) is an aggressive hemato- logical malignancy characterized
by a proliferation of primitive myeloid cells or 'blasts' in the blood. ... 2010 BioMed Central Ltd Acute
myeloid leukemia: leukemia stem cells write a prognostic signature ...
Related articles - All 4 versions

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML Study Group

[HTML] from 171.66.121.246VI Gaidzik, L Bullinger, RF Schlenk… - Journal of Clinical …, 2011 - 171.66.121.246
... RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and
Clinical Analysis From the AML Study Group. ... Abstract. Purpose To evaluate frequency, biologic
features, and clinical relevance of RUNX1 mutations in acute myeloid leukemia (AML). ...
Cited by 3 - Related articles - All 6 versions

Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients With Acute Myeloid Leukemia: Prognostic Significance and the Potential …

[HTML] from jcojournal.orgY Chen, J Cortes, Z Estrov, S Faderl… - Journal of Clinical …, 2011 - jcojournal.org
... INTRODUCTION. Acute myeloid leukemia (AML) is a heterogeneous group of clonal
hematopoietic progenitor cell disorders. ... (1992) Cytogeneticcs for detection of minimal
residual disease in acute myeloblastic leukemia. Leukemia 6:500–506. ...
Related articles - All 5 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451